litlas
Log inCreate account

Lisa Bero

Active 1991–2025

129
Papers
22,225
Citations
75
h-index
120
i10-index

Citations

Citations per year for Lisa Bero1975: 1 citations1978: 2 citations1993: 5 citations1994: 7 citations1995: 4 citations1996: 8 citations1997: 24 citations1998: 22 citations1999: 32 citations2000: 56 citations2001: 54 citations2002: 85 citations2003: 111 citations2004: 109 citations2005: 126 citations2006: 125 citations2007: 118 citations2008: 124 citations2009: 181 citations2010: 142 citations2011: 120 citations2012: 139 citations2013: 167 citations2014: 162 citations2015: 125 citations2016: 145 citations2017: 163 citations2018: 162 citations2019: 500 citations2020: 544 citations2021: 544 citations2022: 374 citations2023: 292 citations2024: 388 citations2025: 186 citations2026: 9 citations1976–1977: no citations, so these years are not shown1979–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,707 citing papers, 21.3% of this breakdownUnited Kingdom: 986 citing papers, 12.3% of this breakdownCanada: 719 citing papers, 9% of this breakdownAustralia: 608 citing papers, 7.6% of this breakdownNetherlands: 325 citing papers, 4% of this breakdownGermany: 312 citing papers, 3.9% of this breakdownSwitzerland: 230 citing papers, 2.9% of this breakdownChina: 208 citing papers, 2.6% of this breakdownItaly: 205 citing papers, 2.6% of this breakdownDenmark: 195 citing papers, 2.4% of this breakdownFrance: 185 citing papers, 2.3% of this breakdownSpain: 176 citing papers, 2.2% of this breakdown
0%21.3%Other 26.9%

Institutions

Fields

  • Medicine41.8%
  • Health Professions15.7%
  • Decision Sciences9.1%
  • Pharmacology, Toxicology and Pharmaceutics7.2%
  • Social Sciences3.7%
  • Computer Science3.7%
  • Other18.8%

Topics

  • Health Policy Implementation Science4.5%
  • Meta-analysis and systematic reviews4.4%
  • Pharmaceutical industry and healthcare3.5%
  • Health Systems, Economic Evaluations, Quality of Life2.5%
  • Clinical practice guidelines implementation2.2%
  • Pharmaceutical Practices and Patient Outcomes2%
  • Other80.9%

Coauthors

All papers

Open in search
  1. Industry sponsorship and research outcome

    Authors: Andreas Lundh, Joel Lexchin, Barbara Mintzes, Jeppe Bennekou Schroll, Lisa Bero - Cochrane Database of Systematic Reviews 2017 cited by 1,587

  2. The risk of bias in observational studies of exposures (ROBINS-E) tool: concerns arising from application to observational studies of exposures

    Authors: Lisa Bero, Nicholas Chartres, Joanna Diong, Alice Fabbri, Davina Ghersi, Juleen Lam, Agnes Lau, Sally McDonald, Barbara Mintzes, Patrice Sutton, Jessica L. Turton, Tracey J. Woodruff - Systematic Reviews 2018 cited by 282

  3. Measuring the effectiveness of scientific gatekeeping

    Authors: Kyle Siler, Kirby Lee, Lisa Bero - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 329

  4. The Influence of Industry Sponsorship on the Research Agenda: A Scoping Review

    Authors: Alice Fabbri, Alexandra Lai, Quinn Grundy, Lisa Bero - American Journal of Public Health 2018 cited by 307

  5. GRADE: Assessing the quality of evidence in environmental and occupational health

    Authors: Rebecca L. Morgan, Kristina A. Thayer, Lisa Bero, Nigel Bruce, Yngve Falck–Ytter, Davina Ghersi, Gordon Guyatt, Carlijn R. Hooijmans, Miranda Langendam, Daniele Mandrioli, Reem A. Mustafa, Eva Rehfuess, Andrew A. Rooney, Beverley Shea, Ellen K. Silbergeld, Patrice Sutton, Mary S. Wolfe, Tracey J. Woodruff, Jos Verbeek, Alison C. Holloway, Nancy Santesso, Holger J. Schünemann - Environment International 2016 cited by 267

  6. Digital contact tracing technologies in epidemics: a rapid review

    Authors: Andrew Anglemyer, Theresa HM Moore, Lisa Parker, Tim Chambers, Alice Grady, Kellia Chiu, Matthew Parry, Magdalena Wilczynska, Ella Flemyng, Lisa Bero - Cochrane Database of Systematic Reviews 2020 cited by 227

  7. Experts identified warning signs of fraudulent research: a qualitative study to inform a screening tool

    Authors: Lisa Parker, Stephanie Boughton, Rosa Lawrence, Lisa Bero - Journal of Clinical Epidemiology 2022 cited by 48

  8. Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review

    Authors: Camilla Hansen Nejstgaard, Lisa Bero, Asbjørn Hróbjartsson, Anders W Jørgensen, Karsten Juhl Jørgensen, Mary Le, Andreas Lundh - BMJ 2020 cited by 115

  9. Changing provider behavior: an overview of systematic reviews of interventions.

    Authors: Jeremy Grimshaw, Liz Shirran, Ruth Thomas, G Mowatt, Cynthia Fraser, Lisa Bero, Roberto Grilli, Emma Harvey, Andy Oxman, Mary Ann O’Brien - 2001 cited by 1,724

  10. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials

    Authors: Andrew Anglemyer, Hacsi Horváth, Lisa Bero - Cochrane Database of Systematic Reviews 2014 cited by 533

  11. ‘Spin’ in published biomedical literature: A methodological systematic review

    Authors: Kellia Chiu, Quinn Grundy, Lisa Bero - PLoS Biology 2017 cited by 317

  12. The advantages and limitations of guideline adaptation frameworks

    Authors: Zhicheng Wang, Susan L. Norris, Lisa Bero - Implementation Science 2018 cited by 200

  13. The IARC Monographs: Updated Procedures for Modern and Transparent Evidence Synthesis in Cancer Hazard Identification

    Authors: Jonathan M. Samet, Weihsueh A. Chiu, Vincent Cogliano, Jennifer Jinot, David Kriebel, Ruth M. Lunn, Frederick A. Beland, Lisa Bero, Patience Browne, Lin Fritschi, Jun Kanno, Dirk W. Lachenmeier, Qing Lan, Gérard Lasfargues, Frank Le Curieux, Susan Peters, Pamela Shubat, Hideko Sone, Mary C. White, Jon Williamson, Marianna G. Yakubovskaya, Jack Siemiatycki, Paul A. White, Kathryn Z. Guyton, Mary K. Schubauer‐Berigan, Amy Hall, Yann Grosse, Véronique Bouvard, Lamia Benbrahim‐Tallaa, Fatiha El Ghissassi, Béatrice Secretan, Bruce K. Armstrong, Rodolfo Saracci, Jiří Zavadil, Kurt Straíf, Christopher P. Wild - JNCI Journal of the National Cancer Institute 2019 cited by 163

  14. Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations

    Authors: Aili Langford, Christine CW Lin, Lisa Bero, Fiona Blyth, Jason N. Doctor, Simon Holliday, Yun‐Hee Jeon, Joanna C. Moullin, Bridin Murnion, Suzanne Nielsen, Rawa Osman, Jonathan Penm, Emily Reeve, Sharon Reid, Janet Wale, Carl R. Schneider, Danijela Gnjidic - The Medical Journal of Australia 2023 cited by 63

  15. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials: a meta-epidemiological study

    Authors: Ingrid Toews, Andrew Anglemyer, John LZ Nyirenda, Dima Alsaid, Sara Balduzzi, Kathrin Grummich, Lukas Schwingshackl, Lisa Bero - Cochrane Database of Systematic Reviews 2024 cited by 55

  16. Data sharing practices of medicines related apps and the mobile ecosystem: traffic, content, and network analysis

    Authors: Quinn Grundy, Kellia Chiu, Fabian Held, Andrea Continella, Lisa Bero, Ralph Holz - BMJ 2019 cited by 158

  17. Creating effective interrupted time series graphs: Review and recommendations

    Authors: Simon Turner, Amalia Karahalios, Andrew Forbes, Monica Taljaard, Jeremy Grimshaw, Elizabeth Korevaar, Allen Cheng, Lisa Bero, Joanne E. McKenzie - Research Synthesis Methods 2020 cited by 63

  18. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings

    Authors: Lisa Bero, Roberto Grilli, Jeremy Grimshaw, Emma Harvey, AD Oxman, Mary Ann Thomson - BMJ 1998 cited by 2,377

  19. Public Health Chronicles

    Authors: Lisa Bero - Public Health Reports 2005 cited by 231

  20. Industry sponsorship and research outcome: systematic review with meta-analysis

    Authors: Andreas Lundh, Joel Lexchin, Barbara Mintzes, Jeppe Bennekou Schroll, Lisa Bero - Intensive Care Medicine 2018 cited by 163

  21. Mechanisms for addressing and managing the influence of corporations on public health policy, research and practice: a scoping review

    Authors: Mélissa Mialon, Stefanie Vandevijvere, Angela Carriedo‐Lutzenkirchen, Lisa Bero, Fábio da Silva Gomes, Mark Petticrew, Martin McKee, David Stückler, Gary Sacks - BMJ Open 2020 cited by 134

  22. Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions

    Authors: Jack Wilkinson, Calvin Heal, George Α. Antoniou, Ella Flemyng, Žarko Alfirević, Alison Avenell, Ginny Barbour, Nicholas J. L. Brown, J. B. Carlisle, Mike Clarke, Patrick Dicker, Jo C Dumville, Andrew Grey, Steph Grohmann, Lyle C. Gurrin, Jill A. Hayden, James Heathers, Kylie E Hunter, Toby J Lasserson, Emily Lam, Sarah Lensen, Tianjing Li, Wentao Li, Elizabeth Loder, Andreas Lundh, Gideon Meyerowitz‐Katz, Ben W. Mol, Neil E O’Connell, Lisa Parker, Barbara K. Redman, Anna Lene Seidler, Kyle Sheldrick, Emma Sydenham, David Torgerson, Madelon van Wely, Rui Wang, Lisa Bero, Jamie J Kirkham - BMJ Open 2024 cited by 37

  23. When beauty is but skin deep: dealing with problematic studies in systematic reviews

    Authors: Stephanie Boughton, Jack Wilkinson, Lisa Bero - Cochrane Database of Systematic Reviews 2021 cited by 34

  24. Changing Provider Behavior

    Authors: Jeremy Grimshaw, Liz Shirran, Ruth Thomas, G Mowatt, Cynthia Fraser, Lisa Bero, Roberto Grilli, Emma Harvey, Andy Oxman, Mary Ann O’Brien - Medical Care 2001 cited by 782